Security
AGILE THERAPEUTICS INC Common Stock · AGRX
AGRXOTCCommon stockHistorical · closed Aug 26, 2024CIK 1261249Updated Nov 16, 2026
AGRX price & chart
Historical security
This listing closed Aug 26, 2024. Live provider charts are shown only for current listings.
In the news
No coverage from other publishers is available.
Recent filings
Show 5 more recent filings
Financials
FY 2023 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 10,255,000Source | 29,299,000Source | 39,333,000Source | 73,062,000Source |
| Property, Plant and Equipment, NetUSD | 75,000Source | 12,047,000Source | 12,447,000Source | 14,243,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 2,557,000Source | 3,743,000Source | 19,143,000Source | 14,463,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 3,392,000Source | 1,665,000Source | 1,533,000Source | 865,000Source |
| Inventory, NetUSD | 2,738,000Source | 2,693,000Source | 966,000Source | 100,000Source |
| Assets, CurrentUSD | 9,530,000Source | 14,352,000Source | 23,925,000Source | 56,785,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 843,000Source | 1,576,000Source | 2,283,000Source | — |
| Operating Lease, Right-of-Use AssetUSD | 412,000Source | 888,000Source | 949,000Source | 138,000Source |
| Other Assets, NoncurrentUSD | 238,000Source | 2,012,000Source | 2,012,000Source | 1,896,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 26,573,000Source | 34,657,000Source | 30,062,000Source | 23,734,000Source |
| Stockholders’ equity: | ||||
| Common Stock, Value, IssuedUSD | 4,000Source | — | 12,000Source | 9,000Source |
| Additional Paid in CapitalUSD | 406,846,000Source | 388,317,000Source | 396,376,000Source | 361,539,000Source |
| Retained Earnings (Accumulated Deficit)USD | -423,168,000Source | -393,675,000Source | -387,117,000Source | -312,223,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | — | — | — | 3,000Source |
| Stockholders' Equity Attributable to ParentUSD | -16,318,000Source | -5,358,000Source | 9,271,000Source | 49,328,000Source |
| Liabilities and EquityUSD | 10,255,000Source | 29,299,000Source | 39,333,000Source | 73,062,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 20,777,000Source | 25,848,000Source | 29,278,000Source | 7,353,000Source |
| Operating Lease, Liability, CurrentUSD | 366,000Source | 231,000Source | 175,000Source | 138,000Source |
| Accounts Payable, CurrentUSD | 9,574,000Source | 9,537,000Source | 8,707,000Source | 3,867,000Source |
| Operating Lease, Liability, NoncurrentUSD | 100,000Source | 708,000Source | 784,000Source | — |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | 9,131,000Source | 3,828,000Source | 3,563,000Source | 3,348,000Source |
| Long-term DebtUSD | 1,515,000Source | — | 16,833,000Source | 16,381,000Source |
| Long-term Debt, Current MaturitiesUSD | 1,515,000Source | 12,252,000Source | 16,833,000Source | — |
cash flow · annual statements
| Line item | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | -14,465,000Source | -25,412,000Source | -74,894,000Source | -51,853,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Share-based Payment Arrangement, Noncash ExpenseUSD | 1,981,000Source | 2,493,000Source | 3,338,000Source | 2,818,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | 15,000Source | 1,844,000Source | 668,000Source | 865,000Source |
| Increase (Decrease) in InventoriesUSD | 2,207,000Source | 366,000Source | 6,289,000Source | — |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -9,577,000Source | -35,947,000Source | -65,202,000Source | -47,311,000Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | -133,000Source | 39,460,000Source | -40,690,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | 133,000Source | 269,000Source | 353,000Source |
| Cash flows from financing activities: | ||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 6,888,000Source | 22,183,000Source | 30,422,000Source | 67,985,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | -2,689,000Source | -13,897,000Source | 4,680,000Source | -20,016,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 2,557,000Source | 5,246,000Source | 19,143,000Source | 14,463,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 356,000Source | 1,162,000Source | 2,383,000Source | 2,099,000Source |
| Additional Financial Items | ||||
| AmortizationUSD | 284,000Source | 254,000Source | 159,000Source | 171,000Source |
| Amortization of Debt Issuance Costs and DiscountsUSD | 1,063,000Source | 1,969,000Source | — | — |
| DepreciationUSD | 102,000Source | 1,280,000Source | 2,064,000Source | 105,000Source |
| Gain (Loss) on Disposition of AssetsUSD | — | -11,122,000Source | — | — |
| General and Administrative ExpenseUSD | 10,505,000Source | 11,860,000Source | 14,698,000Source | 12,735,000Source |
| Income Tax Expense (Benefit)USD | — | -4,675,000Source | — | — |
| Investment Income, InterestUSD | 78,000Source | 80,000Source | 25,000Source | 309,000Source |
| Net Income (Loss) Attributable to ParentUSD | -14,465,000Source | -25,412,000Source | -74,894,000Source | -51,853,000Source |
| Nonoperating Income (Expense)USD | 5,419,000Source | 22,469,000Source | -3,889,000Source | -2,800,000Source |
| Operating ExpensesUSD | 30,499,000Source | 56,604,000Source | 64,388,000Source | 49,520,000Source |
| Operating Lease, ExpenseUSD | 355,000Source | 355,000Source | 180,000,000Source | 190,000Source |
| Payments of Financing CostsUSD | — | — | — | 1,059,000Source |
| Proceeds from Issuance of Long-term DebtUSD | — | — | — | 20,000,000Source |
| Proceeds from Stock Options ExercisedUSD | — | — | 75,000Source | 610,000Source |
income statement · annual statements
| Line item | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Total RevenueUSD | 19,593,000Source | 10,884,000Source | 4,101,000Source | 749,000Source |
| Cost of Goods and Services Sold | — | — | — | — |
| Operating Income (Loss)USD | -19,884,000Source | -52,556,000Source | -71,005,000Source | -49,053,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -14,465,000Source | -30,087,000Source | — | -51,853,000Source |
| Income Tax Expense (Benefit)USD | — | -4,675,000Source | — | — |
| Net Income (Loss) Attributable to ParentUSD | -14,465,000Source | -25,412,000Source | -74,894,000Source | -51,853,000Source |
| Earnings Per Share, BasicUSD per share | -6.71Source | -1.18Source | -0.77Source | — |
| Earnings Per Share, DilutedUSD per share | -6.71Source | -1.18Source | -0.77Source | — |
| Weighted Average Number of Shares Outstanding, Basicshares | 2,156,726Source | 21,610,947Source | 97,072,847Source | — |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 2,156,726Source | 21,610,947Source | 97,072,847Source | — |
| Additional Financial Items | ||||
| General and Administrative ExpenseUSD | 10,505,000Source | 11,860,000Source | 14,698,000Source | 12,735,000Source |
| Gross ProfitUSD | 10,615,000Source | 4,048,000Source | -6,617,000Source | 467,000Source |
| Interest ExpenseUSD | 1,419,000Source | 3,131,000Source | 3,914,000Source | 3,109,000Source |
| Investment Income, InterestUSD | 78,000Source | 80,000Source | 25,000Source | 309,000Source |
| Nonoperating Income (Expense)USD | 5,419,000Source | 22,469,000Source | -3,889,000Source | -2,800,000Source |
| Operating ExpensesUSD | 30,499,000Source | 56,604,000Source | 64,388,000Source | 49,520,000Source |
| Operating Lease, ExpenseUSD | 355,000Source | 355,000Source | 180,000,000Source | 190,000Source |
| Research and Development ExpenseUSD | 2,225,000Source | 3,253,000Source | 6,246,000Source | 13,500,000Source |
| Selling and Marketing ExpenseUSD | 17,769,000Source | 30,369,000Source | 43,444,000Source | 23,285,000Source |